Connect Biopharmaceuticals, a clinical-stage biotech medicine developer, has completed a US$55 million series B round of financing, led by private equity Advantech Capital, according to a company announcement released today.
Chinese Drug Developer Firm Connect Biopharmaceuticals Completes $55 Million Series B Round appeared first on China Money Network.